Endocrinology, Diabetes & Metabolism Doctors in Cambridge, MD Accepting Medicare

2 Endocrinology, Diabetes & Metabolism doctors found. Showing 1 - 2

Dr. Farah Alli, MD Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 505 Byrn St, Cambridge, MD 21613 Phone: 410-221-7770    Fax: 410-221-7863

Cristian P Vilcu, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 503 Byrn St, Ste 1, Cambridge, MD 21613 Phone: 410-221-7770    Fax: 410-221-7863

News Archive

International study into children in care

The 14-month study will examine policy and systems in comparable countries including the UK, USA, New Zealand and Sweden. The aim is to improve the lot of children in care around the world.

Researchers observe how cholera decimates competing bacteria and human cells

Bacteria live in a state of perpetual warfare, with different species battling for dominion over their competitors and when pathogen, over their infected host. New research suggests that the human pathogen Vibrio cholerae, which causes the disease cholera, kills off its microbial rivals by jabbing them with a spring-loaded poison dagger.

Sacral magnetic stimulation effective in refractory stress incontinence

Sacral magnetic stimulation may be an effective treatment for stress urinary incontinence in women whose symptoms are refractory to standard therapies, a clinical trial suggests.

Bioengineering students develop new device that can detect patients with dry eye

Rice University bioengineering students responded to an ophthalmologist's cry for help with a device to diagnose dry eye, the itching and burning sensation that results when a person doesn't produce enough tears or the tears evaporate too quickly.

Researchers use new strategy to develop cancer vaccines

Researchers at National Jewish Health and the University of Colorado School of Medicine have used a new strategy to develop cancer vaccines that are remarkably effective in mice. In the February 16 issue of the Proceedings of the National Academy of Sciences, Kimberly Jordan, PhD, Jill Slansky, PhD, and John Kappler, PhD, report that 100 percent of the mice vaccinated with a peptide they developed remained alive and tumor-free for at least 60 days after inoculation with colon cancer cells.

Read more Medical News

› Verified 2 days ago